Table 1.
Study population characteristics
| Variable (n = 19) | Mean ± SD or median (IQR) or n (%) |
|---|---|
| Age (years) | 57.6 ± 9.8 |
| Sex (% of women) | 8 Women/11 men (42% women) |
| Weight (kg) | 77 (66-94) |
| Body mass index (kg/m2) | 25.9 (22.1-30.9) |
| Current smoking | 3 (16%) |
| Hypertension | 15 (80%) |
| Dyslipidemia | 12 (63%) |
| Family history of early CHD | 0 (0%) |
| Overall cholesterol (mmol/L) | 4.2 ± 0.8 |
| LDL-cholesterol (mmol/L) | 2.3 ± 0.7 |
| HDL-cholesterol (mmol/L) | 1.2 ± 0.3 |
| Triglyceride levels (mmol/L) | 1.2 (0.9-1.8) |
| Fastening insulin (μU/mL) | 10.8 (6.9-21.6) |
| Fastening glucose (mmol/L) | 5.8 (5.4-7.5) |
| HOMA-IR (1) | 3.3 (1.8-5.0) |
| hsCRP (mg/L, normal < 5 mg/L) | 1.1 (0.4-2.8) |
| PON1 (U/L; n = 18) | 79.3 ± 71.7 |
| Arylesterase (U/L; n = 18) | 41.0 (38.9-48.3) |
| Ratio hsCRP/PON1 × 1,000 (mg/U; n = 18) | 47.1 (7.3-312) |
IQR, interquartile range; CHD, coronary heart disease; LDL, low-density lipoprotein; HDL, high-density lipoprotein; HOMA-IR, homeostasis model assessment-insulin resistance; hsCRP, high sensitivity C-reactive protein.